Systemic Mastocytosis

Systemic Mastocytosis is a type of mastocytosis that affects multiple parts of your body, not just the skin. It happens when mast cells grow abnormally in organs like the bone marrow, liver, and spleen. This can lead to symptoms like flushing, itching, and stomach issues. It's a serious condition that needs medical attention.

Condition

What people with Systemic Mastocytosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Ayvakit (Avapritinib) for Systemic Mastocytosis?

NameHow it went

About Systemic Mastocytosis

What It Is

Systemic mastocytosis is a rare disorder in which abnormal mast cells build up in the bone marrow and often in other organs, such as the skin, digestive tract, liver, spleen and lymph nodes. Mast cells are immune cells that release chemicals such as histamine during allergic reactions. When there are too many of them, and they release these chemicals too readily, people can have flushing, itching, stomach cramps, diarrhea, fatigue, lightheadedness, bone pain or trouble concentrating. Many adults also have small reddish-brown spots on the skin that itch or swell when rubbed. Nearly half of people with the condition have a severe allergic reaction (anaphylaxis) at some point, sometimes with no obvious cause. Systemic mastocytosis is a spectrum, and the subtype matters more than the name. About 85 to 90 percent of people have a non-advanced form, most often indolent systemic mastocytosis. These forms cause symptoms but not organ damage, and life expectancy is normal or close to it. Advanced forms (aggressive systemic mastocytosis, systemic mastocytosis with another blood cancer, and mast cell leukemia) damage organs such as the bone marrow, liver or bones and shorten life. Systemic mastocytosis mainly affects adults. It differs from skin-only mastocytosis, which is most common in children and often fades, and from mast cell activation syndrome, which causes similar symptoms without the abnormal mast cell growth that defines mastocytosis.

Causes & Risk Factors

Systemic mastocytosis is caused by a genetic change that arises in a person's own blood-forming cells during life. In most adults it is a change called D816V in KIT, a gene that controls mast cell growth. The change leaves a growth signal in mast cells permanently switched on, so they multiply, live longer and accumulate. Because the change is acquired rather than inherited, the condition is generally not passed on to children, and no habit or exposure is known to cause it. When testing finds additional changes in other blood-cell genes, they are linked with more advanced disease. Triggers are a separate matter: they do not cause the disease, but they can set off symptoms or a severe reaction. Commonly reported triggers include heat, cold, friction or pressure on the skin, bee and wasp stings, alcohol, infections, emotional or physical stress, surgery and anesthesia, and, for some people, medicines such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen or aspirin). Sensitivity varies widely from person to person. Specialists advise identifying your own triggers rather than avoiding everything that has ever been reported; for example, many people tolerate NSAIDs, and a routine low-histamine diet is not generally recommended.

How It's Diagnosed

Doctors suspect systemic mastocytosis in an adult with repeated flushing or fainting episodes, anaphylaxis without a clear cause (especially after an insect sting), or the typical skin spots, particularly when a blood test for tryptase is high. Tryptase is an enzyme released by mast cells. A baseline level, measured when the person is well rather than during a reaction, of 20 ng/mL or higher is one of the diagnostic clues and roughly reflects how many mast cells are in the body. It is not decisive on its own: about 15 percent of people with the disease have a lower level, and a common inherited trait called hereditary alpha-tryptasemia can raise tryptase without mastocytosis, so a genetic test for that trait is sometimes added. Confirming the diagnosis usually requires a bone marrow biopsy. A pathologist looks for dense clusters of mast cells, mast cells with an unusual spindle shape, abnormal markers on their surface, and the KIT D816V change, which can also be measured in a blood sample. The diagnosis rests on a combination of these findings under international criteria. Results can be subtle when mast cell numbers are low, so review by an experienced center matters. The next step is working out the subtype, because it sets both outlook and treatment. Doctors check for signs of organ damage, such as low blood counts from mast cells crowding the marrow, liver problems, poor absorption of nutrients, a very large spleen or bone breakdown with fractures, and for a second blood cancer. A bone density scan (DXA, a low-dose X-ray of the hip and spine) is recommended at diagnosis because bone loss is common.

Treatment Options

Treatment depends on the subtype. For the large majority with non-advanced disease, the goals are to control symptoms, prevent and treat anaphylaxis, and protect the bones. Symptom medicines are added in steps according to which symptoms dominate, and finding the right combination can take some adjustment. Antihistamines come first: the usual allergy antihistamines (H1 blockers) such as cetirizine (Zyrtec) or loratadine (Claritin) for itching, flushing and hives, sometimes at higher than standard doses under a clinician's direction, and stomach-acid antihistamines (H2 blockers) such as famotidine (Pepcid) for digestive symptoms. Oral cromolyn sodium, a mast cell stabilizer, can help persistent digestive symptoms, and montelukast (Singulair), which blocks inflammatory chemicals called leukotrienes, can help flushing and skin symptoms. Steroid tablets are kept for severe symptoms that resist other treatment, because long-term use worsens bone loss. Preparing for anaphylaxis is central. Specialists advise carrying two epinephrine auto-injectors (such as EpiPen), and practicing how to use them, because reactions can be sudden and early epinephrine works best. People with a confirmed bee or wasp venom allergy are advised to have lifelong venom immunotherapy (allergy shots). For repeated anaphylaxis despite other treatment, some specialists use omalizumab (Xolair), an injected antibody that blocks the allergy antibody IgE, as an off-label option. Avapritinib (Ayvakit) is a daily pill that blocks the overactive KIT signal and reduces the number of abnormal mast cells. It is approved by the US Food and Drug Administration (FDA) for adults with indolent systemic mastocytosis. In the trial that led to approval, people whose symptoms stayed moderate to severe despite at least two symptom medicines saw their symptom scores fall more than with a placebo; about one in four had their score cut by half or more, compared with about one in ten on placebo. It is not recommended when the platelet count (blood cells that help clotting) is very low, and it requires periodic blood tests. Its full set of cautions is covered on the avapritinib page. Advanced disease needs treatment aimed at the abnormal cells themselves, to reverse organ damage. Options include avapritinib at a higher dose, midostaurin (Rydapt), another KIT-blocking pill that commonly causes nausea, vomiting and diarrhea, and cladribine, a chemotherapy drug. When mastocytosis occurs with another blood cancer, treatment often targets that cancer first, and a stem cell transplant from a donor may be considered for selected people. Imatinib (Gleevec), an older targeted drug, helps only the rare person whose KIT change is sensitive to it. Bone protection applies to every subtype: vitamin D when levels are low, and bone-strengthening medicines such as bisphosphonates for osteoporosis, with denosumab as an alternative when those are not enough.

What to Expect

In adults, indolent systemic mastocytosis is a lifelong condition that does not go away, but for most people it does not shorten life. The day-to-day burden comes from symptoms that tend to come and go, including flushing, itching, gut upset, fatigue, bone pain and brain fog. Some flares follow a known trigger and others do not. Many people reach a regimen that keeps symptoms manageable, while others need several adjustments or newer targeted treatment. Anxiety and depression are common and often overlooked, and they deserve treatment in their own right. Some situations call for planning ahead. Surgery, anesthesia and scans that use contrast dye can provoke reactions, so the specialist, anesthesiologist and surgeon should plan them together, ideally in a hospital with emergency care on hand. Most people with non-advanced disease go through pregnancy without major complications, although symptoms can change and delivery should be planned with the care team. Vaccines are generally safe; people who have reacted before may be given antihistamines beforehand. Regular follow-up, often with an allergist-immunologist and a hematologist (blood specialist), reviews symptoms and medicines, tracks tryptase as a rough guide to mast cell burden, repeats bone density scans as needed and watches for signs of progression. Care at a center experienced in mast cell disorders is recommended. Advanced forms are more serious and shorten life expectancy to a degree that varies widely with the subtype and how the disease responds to treatment; targeted drugs have broadened the options in recent years.

When to Seek Help

Ask for an evaluation if you have repeated episodes of flushing with lightheadedness or fainting, anaphylaxis without a clear cause, a severe reaction to an insect sting, or itchy brownish skin spots that appeared in adulthood. If you already have the diagnosis, contact your care team when symptoms break through your usual treatment, well before any planned surgery or procedure, or if you notice unexplained weight loss, a swollen belly or a broken bone, which can signal changes that need checking. Signs of anaphylaxis, such as trouble breathing or wheezing, throat tightness or trouble swallowing, swelling of the lips or tongue, or feeling faint or passing out, need immediate treatment: use your epinephrine auto-injector right away and call 911.

Questions to Ask Your Doctor

  1. 1.Which subtype of systemic mastocytosis do I have, and what does it mean for my outlook?
  2. 2.Which triggers matter for me specifically, and which common warnings can I safely ignore?
  3. 3.When should I use my epinephrine auto-injector, and what should my written anaphylaxis plan say?
  4. 4.How will we check and protect my bone health, and how often should I have a bone density scan?
  5. 5.Would a KIT-targeted medicine such as avapritinib make sense for me, and how would we judge whether it is working?

Last reviewed • Oct 2026

Educational content, not medical advice.